Ronan Kelly
MD, MBA
Director, Charles A. Sammons Cancer Center
👥Biography 个人简介
Ronan Kelly led key immunotherapy trials in esophageal and gastroesophageal junction cancers, including the CHECKMATE-577 trial that established adjuvant nivolumab as standard of care for patients with residual disease after neoadjuvant chemoradiation. His research spans PD-L1 biomarker evaluation, HER2-targeting strategies, and combination immunotherapy approaches in esophageal malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ronan Kelly 的研究动态
Follow Ronan Kelly's research updates
留下邮箱，当我们发布与 Ronan Kelly（Baylor University Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment